熱門資訊> 正文
SELLAS Life Sciences Group申请2亿美元混合货架
2024-03-29 04:54
- SELLAS Life Sciences Group (NASDAQ:SLS) on Thursday filed a prospectus for a mixed securities shelf offering of up to $200M.
- This prospectus is not an offer to sell these securities.
- Press Release
More on SELLAS Life Sciences
- SELLAS Life Sciences looks to raise $20M in a direct offering
- Sellas Life Sciences gains on securing orphan drug status for r/r PTCL treatment
- Seeking Alpha’s Quant Rating on SELLAS Life Sciences
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。